{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T08:08:44Z","timestamp":1773302924410,"version":"3.50.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Drug Investig"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1007\/s40261-022-01205-y","type":"journal-article","created":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T03:50:01Z","timestamp":1664596201000},"page":"909-919","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Effects of Cannabidiol on Appetite and Body Weight: A Systematic Review"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8224-3799","authenticated-orcid":false,"given":"Joaquim S.","family":"Pinto","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0525-3416","authenticated-orcid":false,"given":"F\u00e1tima","family":"Martel","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2022,10,1]]},"reference":[{"key":"1205_CR1","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1007\/s40265-018-0996-1","volume":"78","author":"AI Fraguas-S\u00e1nchez","year":"2018","unstructured":"Fraguas-S\u00e1nchez AI, Torres-Su\u00e1rez AI. Medical use of cannabinoids. Drugs. 2018;78:1665\u2013703. https:\/\/doi.org\/10.1007\/s40265-018-0996-1.","journal-title":"Drugs"},{"key":"1205_CR2","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.bcp.2018.07.048","volume":"157","author":"JA Uranga","year":"2018","unstructured":"Uranga JA, Vera G, Abalo R. Cannabinoid pharmacology and therapy in gut disorders. Biochem Pharmacol. 2018;157:134\u201347. https:\/\/doi.org\/10.1016\/j.bcp.2018.07.048.","journal-title":"Biochem Pharmacol"},{"issue":"17","key":"1205_CR3","doi-asserted-by":"publisher","first-page":"9472","DOI":"10.3390\/ijms22179472","volume":"22","author":"H Lowe","year":"2021","unstructured":"Lowe H, Toyang N, Steele B, et al. The endocannabinoid system: a potential target for the treatment of various diseases. Int J Mol Sci. 2021;22(17):9472. https:\/\/doi.org\/10.3390\/ijms22179472.","journal-title":"Int J Mol Sci"},{"key":"1205_CR4","unstructured":"WHO. Cannabidiol (CBD): World Health Organization Expert Committee on Drug Dependence Thirty\u2010ninth Meeting. 2017. Available from: https:\/\/www.who.int\/medicines\/access\/controlled-substances\/5.2_ CBD.pdf. Accessed 10 Jan 2022."},{"key":"1205_CR5","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.pharmthera.2018.10.006","volume":"195","author":"MAP Bloomfield","year":"2019","unstructured":"Bloomfield MAP, Hindocha C, Green SF, et al. The neuropsychopharmacology of cannabis: a review of human imaging studies. Pharmacol Ther. 2019;195:132\u201361. https:\/\/doi.org\/10.1016\/j.pharmthera.2018.10.006.","journal-title":"Pharmacol Ther"},{"issue":"11","key":"1205_CR6","doi-asserted-by":"publisher","first-page":"2463","DOI":"10.1111\/bcp.13618","volume":"84","author":"CPL Grof","year":"2018","unstructured":"Grof CPL. Cannabis, from plant to pill. Br J Clin Pharmacol. 2018;84(11):2463\u20137. https:\/\/doi.org\/10.1111\/bcp.13618.","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"1205_CR7","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1111\/bph.12944","volume":"172","author":"JM McPartland","year":"2015","unstructured":"McPartland JM, Duncan M, Di Marzo V, et al. Are cannabidiol and \u0394(9) -tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review. Br J Pharmacol. 2015;172(3):737\u201353. https:\/\/doi.org\/10.1111\/bph.12944.","journal-title":"Br J Pharmacol."},{"issue":"5","key":"1205_CR8","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1002\/ptr.4781","volume":"27","author":"G Esposito","year":"2013","unstructured":"Esposito G, Filippis DD, Cirillo C, et al. Cannabidiol in inflammatory bowel diseases: a brief overview. Phytother Res. 2013;27(5):633\u20136. https:\/\/doi.org\/10.1002\/ptr.4781.","journal-title":"Phytother Res"},{"issue":"1","key":"1205_CR9","doi-asserted-by":"publisher","first-page":"7","DOI":"10.11607\/ofph.1274","volume":"29","author":"DG Boychuk","year":"2015","unstructured":"Boychuk DG, Goddard G, Mauro G, et al. The effectiveness of cannabinoids in the management of chronic nonmalignant neuropathic pain: a systematic review. J Oral Facial Pain Headache. 2015;29(1):7\u201314. https:\/\/doi.org\/10.11607\/ofph.1274.","journal-title":"J Oral Facial Pain Headache"},{"issue":"3","key":"1205_CR10","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/S1474-4422(15)00379-8","volume":"15","author":"O Devinsky","year":"2016","unstructured":"Devinsky O, Marsh E, Friedman D, et al. Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial. Lancet Neurol. 2016;15(3):270\u20138. https:\/\/doi.org\/10.1016\/S1474-4422(15)00379-8.","journal-title":"Lancet Neurol"},{"key":"1205_CR11","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l1141","volume":"365","author":"TP Freeman","year":"2019","unstructured":"Freeman TP, Hindocha C, Green SF, et al. Medicinal use of cannabis based products and cannabinoids. BMJ. 2019;365: l1141. https:\/\/doi.org\/10.1136\/bmj.l1141.","journal-title":"BMJ"},{"issue":"1","key":"1205_CR12","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1159\/000489287","volume":"1","author":"A Hazekamp","year":"2018","unstructured":"Hazekamp A. The trouble with CBD oil. Med Cannabis Cannabinoids. 2018;1(1):65\u201372. https:\/\/doi.org\/10.1159\/000489287.","journal-title":"Med Cannabis Cannabinoids."},{"issue":"12","key":"1205_CR13","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1007\/s11906-020-01112-7","volume":"22","author":"C Navarrete","year":"2020","unstructured":"Navarrete C, Garcia-Martin A, DeMesa J, et al. Cannabinoids in metabolic syndrome and cardiac fibrosis. Curr Hypertens Rep. 2020;22(12):98. https:\/\/doi.org\/10.1007\/s11906-020-01112-7.","journal-title":"Curr Hypertens Rep"},{"key":"1205_CR14","doi-asserted-by":"publisher","DOI":"10.1515\/hmbci-2018-0013","author":"A Mastinu","year":"2018","unstructured":"Mastinu A, Premoli M, Ferrari-Toninelli G, et al. Cannabinoids in health and disease: pharmacological potential in metabolic syndrome and neuroinflammation. Horm Mol Biol Clin Investig. 2018. https:\/\/doi.org\/10.1515\/hmbci-2018-0013.","journal-title":"Horm Mol Biol Clin Investig."},{"issue":"9","key":"1205_CR15","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.3390\/ijms19092690","volume":"19","author":"F Rossi","year":"2018","unstructured":"Rossi F, Punzo F, Umano GR, et al. Role of cannabinoids in obesity. Int J Mol Sci. 2018;19(9):2690. https:\/\/doi.org\/10.3390\/ijms19092690.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"1205_CR16","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1097\/MOL.0b013e328304b62b","volume":"19","author":"D Jesudason","year":"2008","unstructured":"Jesudason D, Wittert G. Endocannabinoid system in food intake and metabolic regulation. Curr Opin Lipidol. 2008;19(4):344\u20138. https:\/\/doi.org\/10.1097\/MOL.0b013e328304b62b.","journal-title":"Curr Opin Lipidol"},{"key":"1205_CR17","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372: n71. https:\/\/doi.org\/10.1136\/bmj.n71.","journal-title":"BMJ"},{"issue":"1","key":"1205_CR18","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1089\/can.2017.0018","volume":"2","author":"SEM de Bruijn","year":"2017","unstructured":"de Bruijn SEM, de Graaf C, Witkamp RF, et al. Explorative placebo-controlled double-blind intervention study with low doses of inhaled \u03949-tetrahydrocannabinol and cannabidiol reveals no effect on sweet taste intensity perception and liking in humans. Cannabis Cannabinoid Res. 2017;2(1):114\u201322. https:\/\/doi.org\/10.1089\/can.2017.0018.","journal-title":"Cannabis Cannabinoid Res."},{"issue":"3","key":"1205_CR19","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1177\/0269881117737400","volume":"32","author":"H Hundal","year":"2018","unstructured":"Hundal H, Lister R, Evans N, et al. The effects of cannabidiol on persecutory ideation and anxiety in a high trait paranoid group. J Psychopharmacol. 2018;32(3):276\u201382. https:\/\/doi.org\/10.1177\/0269881117737400.","journal-title":"J Psychopharmacol"},{"issue":"10","key":"1205_CR20","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.2337\/dc16-0650","volume":"39","author":"KA Jadoon","year":"2016","unstructured":"Jadoon KA, Ratcliffe SH, Barrett DA, et al. Efficacy and safety of cannabidiol and tetrahydrocannabivarin on glycemic and lipid parameters in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, parallel group pilot study. Diabetes Care. 2016;39(10):1777\u201386. https:\/\/doi.org\/10.2337\/dc16-0650.","journal-title":"Diabetes Care"},{"issue":"21","key":"1205_CR21","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1056\/NEJMoa1611618","volume":"376","author":"O Devinsky","year":"2017","unstructured":"Devinsky O, Cross JH, Laux L, et al. Trial of cannabidiol for drug-resistant seizures in the Dravet syndrome. N Engl J Med. 2017;376(21):2011\u201320. https:\/\/doi.org\/10.1056\/NEJMoa1611618.","journal-title":"N Engl J Med"},{"issue":"14","key":"1205_CR22","doi-asserted-by":"publisher","first-page":"e1204","DOI":"10.1212\/WNL.000000000000525","volume":"90","author":"O Devinsky","year":"2018","unstructured":"Devinsky O, Patel AD, Thiele EA, et al. Randomized, dose-ranging safety trial of cannabidiol in Dravet syndrome. Neurology. 2018;90(14):e1204\u201311. https:\/\/doi.org\/10.1212\/WNL.000000000000525.","journal-title":"Neurology"},{"issue":"5","key":"1205_CR23","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1001\/jamaneurol.2020.0073","volume":"77","author":"I Miller","year":"2020","unstructured":"Miller I, Scheffer IE, Gunning B, et al. Dose-ranging effect of adjunctive oral cannabidiol vs placebo on convulsive seizure frequency in Dravet syndrome: a randomized clinical trial. JAMA Neurol. 2020;77(5):613\u201321. https:\/\/doi.org\/10.1001\/jamaneurol.2020.0073.","journal-title":"JAMA Neurol"},{"issue":"20","key":"1205_CR24","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1056\/NEJMoa1714631","volume":"378","author":"O Devinsky","year":"2018","unstructured":"Devinsky O, Patel AD, Cross JH, et al. Effect of cannabidiol on drop seizures in the Lennox-Gastaut syndrome. N Engl J Med. 2018;378(20):1888\u201397. https:\/\/doi.org\/10.1056\/NEJMoa1714631.","journal-title":"N Engl J Med"},{"issue":"10125","key":"1205_CR25","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/S0140-6736(18)30136-3","volume":"391","author":"EA Thiele","year":"2018","unstructured":"Thiele EA, Marsh ED, French JA, et al. Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet. 2018;391(10125):1085\u201396. https:\/\/doi.org\/10.1016\/S0140-6736(18)30136-3.","journal-title":"Lancet"},{"issue":"1","key":"1205_CR26","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13229-021-00420-2","volume":"12","author":"A Aran","year":"2021","unstructured":"Aran A, Harel M, Cassuto H, et al. Cannabinoid treatment for autism: a proof-of-concept randomized trial. Mol Autism. 2021;12(1):6. https:\/\/doi.org\/10.1186\/s13229-021-00420-2.","journal-title":"Mol Autism."},{"key":"1205_CR27","doi-asserted-by":"publisher","DOI":"10.1089\/can.2021.0093","author":"JAS Crippa","year":"2021","unstructured":"Crippa JAS, Pacheco JC, Zuardi AW, et al. Cannabidiol for COVID-19 patients with mild to moderate symptoms (CANDIDATE Study): a randomized, double-blind, placebo-controlled clinical trial. Cannabis Cannabinoid Res. 2021. https:\/\/doi.org\/10.1089\/can.2021.0093.","journal-title":"Cannabis Cannabinoid Res."},{"issue":"Pt A","key":"1205_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2020.106938","volume":"104","author":"L Taylor","year":"2020","unstructured":"Taylor L, Crockett J, Tayo B, et al. Abrupt withdrawal of cannabidiol (CBD): a randomized trial. Epilepsy Behav. 2020;104(Pt A): 106938. https:\/\/doi.org\/10.1016\/j.yebeh.2020.106938.","journal-title":"Epilepsy Behav"},{"key":"1205_CR29","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.yebeh.2015.04.009","volume":"47","author":"S Hussain","year":"2015","unstructured":"Hussain S, Zhou R, Jacobson C, et al. Perceived efficacy of cannabidiol-enriched cannabis extracts for treatment of pediatric epilepsy: a potential role for infantile spasms and Lennox-Gastaut syndrome. Epilepsy Behav. 2015;47:138\u201341. https:\/\/doi.org\/10.1016\/j.yebeh.2015.04.009.","journal-title":"Epilepsy Behav."},{"key":"1205_CR30","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.neuropharm.2017.05.033","volume":"124","author":"BK Lau","year":"2017","unstructured":"Lau BK, Cota D, Cristino L, et al. Endocannabinoid modulation of homeostatic and non-homeostatic feeding circuits. Neuropharmacology. 2017;124:38\u201351. https:\/\/doi.org\/10.1016\/j.neuropharm.2017.05.033.","journal-title":"Neuropharmacology"},{"issue":"2","key":"1205_CR31","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/0885-3924(94)00117-4","volume":"10","author":"JE Beal","year":"1995","unstructured":"Beal JE, Olson R, Laubenstein L, et al. Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS. J Pain Symptom Manag. 1995;10(2):89\u201397. https:\/\/doi.org\/10.1016\/0885-3924(94)00117-4.","journal-title":"J Pain Symptom Manag"},{"issue":"3","key":"1205_CR32","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/0091-3057(91)90385-f","volume":"40","author":"TF Plasse","year":"1991","unstructured":"Plasse TF, Gorter RW, Krasnow SH, et al. Recent clinical experience with dronabinol. Pharmacol Biochem Behav. 1991;40(3):695\u2013700. https:\/\/doi.org\/10.1016\/0091-3057(91)90385-f.","journal-title":"Pharmacol Biochem Behav"},{"key":"1205_CR33","doi-asserted-by":"publisher","first-page":"6162","DOI":"10.1002\/14651858.CD006162.pub2","volume":"4","author":"C Curioni","year":"2006","unstructured":"Curioni C, Andr\u00e9 C. Rimonabant for overweight or obesity. Cochrane Database Syst Rev. 2006;4:6162. https:\/\/doi.org\/10.1002\/14651858.CD006162.pub2.","journal-title":"Cochrane Database Syst Rev"},{"key":"1205_CR34","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/432607","volume":"2011","author":"AH Sam","year":"2011","unstructured":"Sam AH, Salem V. Ghatei MA Rimonabant: from RIO to Ban. J Obes. 2011;2011: 432607. https:\/\/doi.org\/10.1155\/2011\/432607.","journal-title":"J Obes"},{"issue":"2","key":"1205_CR35","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/sj.bjp.0707442","volume":"153","author":"RG Pertwee","year":"2008","unstructured":"Pertwee RG. The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin. Br J Pharmacol. 2008;153(2):199\u2013215. https:\/\/doi.org\/10.1038\/sj.bjp.0707442.","journal-title":"Br J Pharmacol"},{"key":"1205_CR36","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/bs.podrm.2018.11.005","volume":"44","author":"NY Khalil","year":"2019","unstructured":"Khalil NY, AlRabiah HK, Al Rashoud SS, et al. Topiramate: comprehensive profile. Profiles Drug Subst Excip Relat Methodol. 2019;44:333\u201378. https:\/\/doi.org\/10.1016\/bs.podrm.2018.11.005.","journal-title":"Profiles Drug Subst Excip Relat Methodol."},{"issue":"2","key":"1205_CR37","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1053\/j.jrn.2015.09.002","volume":"26","author":"A Molfino","year":"2016","unstructured":"Molfino A, Kaysen GA, Chertow GM, et al. Validating appetite assessment tools among patients receiving hemodialysis. J Ren Nutr. 2016;26(2):103\u201310. https:\/\/doi.org\/10.1053\/j.jrn.2015.09.002.","journal-title":"J Ren Nutr"},{"issue":"1","key":"1205_CR38","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.neulet.2010.12.031","volume":"490","author":"B Ignatowska-Jankowska","year":"2011","unstructured":"Ignatowska-Jankowska B, Jankowski MM, Swiergiel AH. Cannabidiol decreases body weight gain in rats: involvement of CB2 receptors. Neurosci Lett. 2011;490(1):82\u20134. https:\/\/doi.org\/10.1016\/j.neulet.2010.12.031.","journal-title":"Neurosci Lett"},{"issue":"6","key":"1205_CR39","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1002\/ptr.6047","volume":"32","author":"S Ramlugon","year":"2018","unstructured":"Ramlugon S, Levendal R-A, Frost CL. Time-dependent effect of phytocannabinoid treatments in fat cells. Phytother Res. 2018;32(6):1080\u20139. https:\/\/doi.org\/10.1002\/ptr.6047.","journal-title":"Phytother Res"},{"issue":"6","key":"1205_CR40","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1016\/j.jhep.2015.01.001","volume":"62","author":"C Silvestri","year":"2015","unstructured":"Silvestri C, Paris D, Martella A, et al. Two non-psychoactive cannabinoids reduce intracellular lipid levels and inhibit hepatosteatosis. J Hepatol. 2015;62(6):1382\u201390. https:\/\/doi.org\/10.1016\/j.jhep.2015.01.001.","journal-title":"J Hepatol"},{"issue":"1\u20132","key":"1205_CR41","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s11010-016-2702-5","volume":"416","author":"HA Parray","year":"2016","unstructured":"Parray HA, Yun JW. Cannabidiol promotes browning in 3T3-L1 adipocytes. Mol Cell Biochem. 2016;416(1\u20132):131\u20139. https:\/\/doi.org\/10.1007\/s11010-016-2702-5.","journal-title":"Mol Cell Biochem"},{"issue":"12","key":"1205_CR42","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1111\/dom.12780","volume":"18","author":"B Liu","year":"2016","unstructured":"Liu B, Song S, Ruz-Maldonado I, et al. GPR55-dependent stimulation of insulin secretion from isolated mouse and human islets of Langerhans. Diabetes Obes Metab. 2016;18(12):1263\u201373. https:\/\/doi.org\/10.1111\/dom.12780.","journal-title":"Diabetes Obes Metab"},{"issue":"9","key":"1205_CR43","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1007\/s00125-009-1422-8","volume":"52","author":"N Irwin","year":"2009","unstructured":"Irwin N, Flatt PR. Evidence for beneficial effects of compromised gastric inhibitory polypeptide action in obesity-related diabetes and possible therapeutic implications. Diabetologia. 2009;52(9):1724\u201331. https:\/\/doi.org\/10.1007\/s00125-009-1422-8.","journal-title":"Diabetologia"},{"issue":"6818","key":"1205_CR44","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/35053000","volume":"409","author":"CM Steppan","year":"2001","unstructured":"Steppan CM, Bailey ST, Bhat S, et al. The hormone resistin links obesity to diabetes. Nature. 2001;409(6818):307\u201312. https:\/\/doi.org\/10.1038\/35053000.","journal-title":"Nature"},{"key":"1205_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-319-48382-5_1","volume":"960","author":"A Engin","year":"2017","unstructured":"Engin A. The definition and prevalence of obesity and metabolic syndrome. Adv Exp Med Biol. 2017;960:1\u201317. https:\/\/doi.org\/10.1007\/978-3-319-48382-5_1.","journal-title":"Adv Exp Med Biol"},{"key":"1205_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.706978","volume":"12","author":"X Lin","year":"2021","unstructured":"Lin X, Li H. Obesity: epidemiology, pathophysiology, and therapeutics. Front Endocrinol. 2021;12: 706978. https:\/\/doi.org\/10.3389\/fendo.2021.706978.","journal-title":"Front Endocrinol"}],"container-title":["Clinical Drug Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-022-01205-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40261-022-01205-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-022-01205-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T11:11:03Z","timestamp":1744715463000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40261-022-01205-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,1]]},"references-count":46,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["1205"],"URL":"https:\/\/doi.org\/10.1007\/s40261-022-01205-y","relation":{},"ISSN":["1173-2563","1179-1918"],"issn-type":[{"value":"1173-2563","type":"print"},{"value":"1179-1918","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,1]]},"assertion":[{"value":"13 September 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Joaquim S. Pinto was responsible for the article design, data collection, and analysis as well as writing the first draft of the manuscript. F\u00e1tima Martel was responsible for the data collection and analysis as well as reviewing and editing the manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 Contributions"}},{"value":"No funding was received for the preparation of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Joaquim S. Pinto and F\u00e1tima Martel have no conflicts of interest that are directly relevant to the content of this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of Data and Material"}},{"value":"Not applicable.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}}]}}